These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8119305)

  • 1. The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret.
    Tattersall FD; Rycroft W; Hargreaves RJ; Hill RG
    Eur J Pharmacol; 1993 Nov; 250(1):R5-6. PubMed ID: 8119305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets.
    Bountra C; Bunce K; Dale T; Gardner C; Jordan C; Twissell D; Ward P
    Eur J Pharmacol; 1993 Nov; 249(1):R3-4. PubMed ID: 7506663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets.
    Gonsalves S; Watson J; Ashton C
    Eur J Pharmacol; 1996 Jun; 305(1-3):181-5. PubMed ID: 8813551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Jordan CC; Naylor RJ
    Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
    Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
    Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.
    Watson JW; Gonsalves SF; Fossa AA; McLean S; Seeger T; Obach S; Andrews PL
    Br J Pharmacol; 1995 May; 115(1):84-94. PubMed ID: 7544198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.
    Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ
    Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the NK1 receptor antagonist CP-99,994 on emesis and c-fos protein induction by loperamide in the ferret.
    Zaman S; Woods AJ; Watson JW; Reynolds DJ; Andrews PL
    Neuropharmacology; 2000 Jan; 39(2):316-23. PubMed ID: 10670427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994.
    Tattersall FD; Rycroft W; Hill RG; Hargreaves RJ
    Neuropharmacology; 1994 Feb; 33(2):259-60. PubMed ID: 8035913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew).
    Rudd JA; Ngan MP; Wai MK
    Eur J Pharmacol; 1999 Feb; 366(2-3):243-52. PubMed ID: 10082206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists.
    Rupniak NM; Tattersall FD; Williams AR; Rycroft W; Carlson EJ; Cascieri MA; Sadowski S; Ber E; Hale JJ; Mills SG; MacCoss M; Seward E; Huscroft I; Owen S; Swain CJ; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 May; 326(2-3):201-9. PubMed ID: 9196273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994.
    Tattersall FD; Rycroft W; Marmont N; Cascieri M; Hill RG; Hargreaves RJ
    Neuropharmacology; 1995 Dec; 34(12):1697-9. PubMed ID: 8788968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
    Piedimonte G; Bertrand C; Geppetti P; Snider RM; Desai MC; Nadel JA
    J Pharmacol Exp Ther; 1993 Jul; 266(1):270-3. PubMed ID: 7687291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor.
    Watanabe Y; Asai H; Ishii T; Kiuchi S; Okamoto M; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jan; 106(1):121-7. PubMed ID: 18187929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
    Shishido Y; Wakabayashi H; Koike H; Ueno N; Nukui S; Yamagishi T; Murata Y; Naganeo F; Mizutani M; Shimada K; Fujiwara Y; Sakakibara A; Suga O; Kusano R; Ueda S; Kanai Y; Tsuchiya M; Satake K
    Bioorg Med Chem; 2008 Aug; 16(15):7193-205. PubMed ID: 18640044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
    Bristow LJ; Young L
    Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.